Resultats de la cerca - Jenette Creaney

Refinar resultats
  1. 1
    Malignant Mesothelioma Biomarkers

    Malignant Mesothelioma Biomarkers per Jenette Creaney, B. W. Robinson

    Publicat 2016
    Obtenir text complet Obtenir text complet
    Revisão
    Afegir a favorits
    Guardat en:
  2. 2
    Existing models, but not neutrophil-to-lymphocyte ratio, are prognostic in malignant mesothelioma

    Existing models, but not neutrophil-to-lymphocyte ratio, are prognostic in malignant mesothelioma per Tarek Meniawy, Jenette Creaney, Richard Lake, Anna K. Nowak

    Publicat 2013
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  3. 3
    Computational immunogenomic approaches to predict response to cancer immunotherapies

    Computational immunogenomic approaches to predict response to cancer immunotherapies per Venkateswar Addala, Felicity Newell, John V. Pearson, Alec Redwood, B. W. Robinson, Jenette Creaney, Nicola Waddell

    Publicat 2023
    Obtenir text complet Obtenir text complet
    Revisão
    Afegir a favorits
    Guardat en:
  4. 4
    Comparison of Osteopontin, Megakaryocyte Potentiating Factor, and Mesothelin Proteins as Markers in the Serum of Patients with Malignant Mesothelioma

    Comparison of Osteopontin, Megakaryocyte Potentiating Factor, and Mesothelin Proteins as Markers in the Serum of Patients with Malignant Mesothelioma per Jenette Creaney, Deborah Yeoman, Yvonne Demelker, Amanda Segal, Arthur W. Musk, Steven J. Skates, B. W. Robinson

    Publicat 2008
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  5. 5
    Secreted primary human malignant mesothelioma exosome signature reflects oncogenic cargo

    Secreted primary human malignant mesothelioma exosome signature reflects oncogenic cargo per David W. Greening, Hong Ji, Maoshan Chen, Bruce Robinson, Ian M. Dick, Jenette Creaney, Richard J. Simpson

    Publicat 2016
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  6. 6
    The Bloom's Syndrome Protein (BLM) Interacts with MLH1 but Is Not Required for DNA Mismatch Repair

    The Bloom's Syndrome Protein (BLM) Interacts with MLH1 but Is Not Required for DNA Mismatch Repair per Gregory T. Langland, Jennifer J. Kordich, Jenette Creaney, Kathleen H. Goss, Kate Lillard-Wetherell, Katarzyna Bębenek, Thomas A. Kunkel, Joanna Groden

    Publicat 2001
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  7. 7
    Interleukin-5 Transgenic Mice Show Enhanced Resistance to Primary Infections with<i>Nippostrongylus brasiliensis</i>but Not Primary Infections with<i>Toxocara canis</i>

    Interleukin-5 Transgenic Mice Show Enhanced Resistance to Primary Infections with<i>Nippostrongylus brasiliensis</i>but Not Primary Infections with<i>Toxocara canis</i> per Lindsay A. Dent, Christine M. Daly, Graham Mayrhofer, Trudy Zimmerman, Ann Hallett, Leon P. Bignold, Jenette Creaney, Jim C. Parsons

    Publicat 1999
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  8. 8
    Serum Mesothelin for Early Detection of Asbestos-Induced Cancer Malignant Mesothelioma

    Serum Mesothelin for Early Detection of Asbestos-Induced Cancer Malignant Mesothelioma per Jenette Creaney, Nola Olsen, Fraser Brims, Ian M. Dick, Arthur W. Musk, Nicholas de Klerk, Steven J. Skates, B. W. Robinson

    Publicat 2010
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  9. 9
    A Novel Clinical Prediction Model for Prognosis in Malignant Pleural Mesothelioma Using Decision Tree Analysis

    A Novel Clinical Prediction Model for Prognosis in Malignant Pleural Mesothelioma Using Decision Tree Analysis per Fraser Brims, Tarek Meniawy, Ian Duffus, Duneesha de Fonseka, Amanda Segal, Jenette Creaney, Nick Maskell, Richard Lake, Nicholas de Klerk, Anna K. Nowak

    Publicat 2016
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  10. 10
    Soluble mesothelin in effusions: a useful tool for the diagnosis of malignant mesothelioma

    Soluble mesothelin in effusions: a useful tool for the diagnosis of malignant mesothelioma per Jenette Creaney, Deborah Yeoman, L. K Naumoff, Michel H. Hof, Amanda Segal, Arthur W. Musk, Nicholas de Klerk, Nora Horick, Steven J. Skates, Bruce Robinson

    Publicat 2007
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  11. 11
    A Phase II Study of Intermittent Sunitinib Malate as Second-Line Therapy in Progressive Malignant Pleural Mesothelioma

    A Phase II Study of Intermittent Sunitinib Malate as Second-Line Therapy in Progressive Malignant Pleural Mesothelioma per Anna K. Nowak, Michael Millward, Jenette Creaney, Roslyn J. Francis, Ian M. Dick, Arman Hasani, Agatha van der Schaaf, Amanda Segal, Arthur W. Musk, Michael Byrne

    Publicat 2012
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  12. 12
    Characterization of neoantigen-specific T cells in cancer resistant to immune checkpoint therapies

    Characterization of neoantigen-specific T cells in cancer resistant to immune checkpoint therapies per Shamin Li, Yannick Simoni, Summer Zhuang, Austin M. Gabel, Shaokang Ma, Jonathan Chee, Laura Islas, Anthony Cessna, Jenette Creaney, Robert K. Bradley, Alec Redwood, Bruce Robinson, Evan W. Newell

    Publicat 2021
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  13. 13
    Comparison of fibulin-3 and mesothelin as markers in malignant mesothelioma

    Comparison of fibulin-3 and mesothelin as markers in malignant mesothelioma per Jenette Creaney, Ian M. Dick, Tarek Meniawy, Su Lyn Leong, Justine S Leon, Yvonne Demelker, Amanda Segal, Arthur W. Musk, Gary Lee, Steven J. Skates, Anna K. Nowak, B. W. Robinson

    Publicat 2014
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  14. 14
    Guidelines for the Cytopathologic Diagnosis of Epithelioid and Mixed-Type Malignant Mesothelioma

    Guidelines for the Cytopathologic Diagnosis of Epithelioid and Mixed-Type Malignant Mesothelioma per Anders Hjerpe, Valeria Ascoli, Carlos Bedrossian, Mathilde E. Boon, Jenette Creaney, Ben Davidson, Annika Dejmek, Katalin Dobra, Ambrogio Fassina, Andrew Field, Pınar Firat, Toshiaki Kamei, Tadao K. Kobayashi, Claire W. Michael, Sevgen Önder, Amanda Segal, Philippe Vielh

    Publicat 2015
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  15. 15
    Guidelines for cytopathologic diagnosis of epithelioid and mixed type malignant mesothelioma. Complementary statement from the International Mesothelioma Interest Group, also endorsed by the International Academy of Cytology and the Papanicolaou Society of Cytopathology

    Guidelines for cytopathologic diagnosis of epithelioid and mixed type malignant mesothelioma. Complementary statement from the International Mesothelioma Interest Group, also endor... per Anders Hjerpe, Valeria Ascoli, Carlos Bedrossian, Mathilde E. Boon, Jenette Creaney, Ben Davidson, Annika Dejmek, Katalin Dobra, Ambrogio Fassina, Andrew Field, Pınar Firat, Toshiaki Kamei, Tadao K. Kobayashi, Claire W. Michael, Sevgen Önder, Amanda Segal, Philippe Vielh

    Publicat 2015
    Obtenir text complet
    Revisão
    Afegir a favorits
    Guardat en:
  16. 16
    BAP1 Loss by Immunohistochemistry Predicts Improved Survival to First-Line Platinum and Pemetrexed Chemotherapy for Patients With Pleural Mesothelioma: A Validation Study

    BAP1 Loss by Immunohistochemistry Predicts Improved Survival to First-Line Platinum and Pemetrexed Chemotherapy for Patients With Pleural Mesothelioma: A Validation Study per Amber Louw, Vasiliki Panou, Weronika Maria Szejniuk, Christos Meristoudis, Siaw Ming Chai, Chris Van Vliet, Gary Lee, Ian M. Dick, Tina Firth, Louise Andersen Lynggaard, Azadeh Birbaneh Asghari, Mogens Vyberg, Johnni Hansen, Jenette Creaney, Oluf Dimitri Røe

    Publicat 2022
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  17. 17
    Increased Circulating miR-625-3p: A Potential Biomarker for Patients With Malignant Pleural Mesothelioma

    Increased Circulating miR-625-3p: A Potential Biomarker for Patients With Malignant Pleural Mesothelioma per Michaela B. Kirschner, Yuen Yee Cheng, Bahareh Badrian, Steven Kao, Jenette Creaney, J. James Edelman, Nicola J. Armstrong, Michael P. Vallely, Arthur W. Musk, B. W. Robinson, Brian C. McCaughan, Sonja Klebe, Steven E. Mutsaers, Nico van Zandwijk, Glen Reid

    Publicat 2012
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  18. 18
    The nuclear deubiquitinase BAP1 is commonly inactivated by somatic mutations and 3p21.1 losses in malignant pleural mesothelioma

    The nuclear deubiquitinase BAP1 is commonly inactivated by somatic mutations and 3p21.1 losses in malignant pleural mesothelioma per Matthew J. Bott, Marie Brevet, Barry S. Taylor, Shigeki Shimizu, Tatsuo Ito, Lu Wang, Jenette Creaney, Richard Lake, Maureen F. Zakowski, Boris Reva, Chris Sander, Robert Delsite, Simon N. Powell, Qin Zhou, Ronglai Shen, Adam B. Olshen, Valerie W. Rusch, Marc Ladanyi

    Publicat 2011
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  19. 19
    Serum Mesothelin for Diagnosing Malignant Pleural Mesothelioma: An Individual Patient Data Meta-Analysis

    Serum Mesothelin for Diagnosing Malignant Pleural Mesothelioma: An Individual Patient Data Meta-Analysis per Kevin Hollevoet, Johannes B. Reitsma, Jenette Creaney, Bogdan Grigoriu, Bruce Robinson, Arnaud Scherpereel, Alfonso Cristaudo, Harvey I. Pass, Kristiaan Nackaerts, José Antonio Rodríguez Portal, Joachim Schneider, Thomas Muley, Francesca Di Serio, Paul Baas, Marco Tomasetti, J. Alex, Jan P. van Meerbeeck

    Publicat 2012
    Obtenir text complet
    Revisão
    Afegir a favorits
    Guardat en:
  20. 20
    Germline and somatic variant identification using BGISEQ-500 and HiSeq X Ten whole genome sequencing

    Germline and somatic variant identification using BGISEQ-500 and HiSeq X Ten whole genome sequencing per Ann‐Marie Patch, Kátia Nones, Stephen H. Kazakoff, Felicity Newell, Scott Wood, Conrad Leonard, Oliver Holmes, Qinying Xu, Venkateswar Addala, Jenette Creaney, B. W. Robinson, Shujin Fu, Chunyu Geng, Tong Li, Wenwei Zhang, Xinming Liang, Junhua Rao, Jiahao Wang, Mingyu Tian, Yonggang Zhao, Fei Teng, Honglan Gou, Bicheng Yang, Hui Jiang, Feng Mu, John V. Pearson, Nicola Waddell

    Publicat 2018
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:

Eines de cerca: